Rituxan (rituximab) - Roche
The Great Masquerade: Beyond Textbook Seronegative Immune Complex Glomerulopathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0546; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Despite 40–50% IFTA, nephrotic syndrome prompted treatment with RAAS blockade, rituximab (1 g ×2), and corticosteroid taper...(C) Electron microscopy: Mesangial fibrils measuring 12.4–16.4 nm with associated subepithelial deposits. (D) Congo red-positive ALECT2 amyloid deposition." 
Chronic Kidney Disease • Diabetic Nephropathy • Glomerulonephritis • Infectious Disease • Lupus Nephritis • Monoclonal Gammopathy • Nephrology • Renal Disease • Respiratory Diseases • Retinal Disorders • Type 2 Diabetes Mellitus
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559447
 
Kyaw Moe Naing; Elaine J. Oldford; Lemar Ahmad Gardezi; Jose Luis Rayas; Devon Gerard Kent; Hira H. Al-adroos; Keiichi Sumida; Shilpa Sharma; Connie Rhee; Man Kit Michael Siu
 
Oct 2, 2026
 
Prev Next